Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Current Assets (2016 - 2025)

Historic Current Assets for Ascendis Pharma A (ASND) over the last 14 years, with Q4 2025 value amounting to $1.3 billion.

  • Ascendis Pharma A's Current Assets rose 1388.4% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year increase of 1388.4%. This contributed to the annual value of $1.3 billion for FY2025, which is 1055.33% up from last year.
  • According to the latest figures from Q4 2025, Ascendis Pharma A's Current Assets is $1.3 billion, which was up 1388.4% from $1.2 billion recorded in Q3 2025.
  • Over the past 5 years, Ascendis Pharma A's Current Assets peaked at $1.3 billion during Q4 2025, and registered a low of $675.6 million during Q2 2024.
  • For the 5-year period, Ascendis Pharma A's Current Assets averaged around $961.1 million, with its median value being $955.7 million (2022).
  • As far as peak fluctuations go, Ascendis Pharma A's Current Assets surged by 317186.63% in 2021, and later plummeted by 3781.41% in 2023.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Current Assets stood at $794.8 million in 2021, then grew by 18.55% to $942.2 million in 2022, then dropped by 19.75% to $756.1 million in 2023, then soared by 49.93% to $1.1 billion in 2024, then increased by 13.88% to $1.3 billion in 2025.
  • Its Current Assets stands at $1.3 billion for Q4 2025, versus $1.2 billion for Q3 2025 and $1.1 billion for Q2 2025.